NEUROONE MEDICAL TECHNOLOGIES Corp Annual Depreciation in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Depreciation history and growth rate from 2019 to 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Depreciation for the quarter ending September 30, 2024 was $58.5K, a 2.84% increase year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Depreciation for the twelve months ending September 30, 2024 was $224K, a 26.9% increase year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Depreciation for 2024 was $224K, a 26.9% increase from 2023.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Depreciation for 2023 was $177K, a 83.7% increase from 2022.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Depreciation for 2022 was $96.3K, a 64.8% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $224K +$47.5K +26.9% Oct 1, 2023 Sep 30, 2024 10-K 2024-12-17
2023 $177K +$80.6K +83.7% Oct 1, 2022 Sep 30, 2023 10-K 2024-12-17
2022 $96.3K +$37.9K +64.8% Oct 1, 2021 Sep 30, 2022 10-K 2023-12-15
2021 $58.4K +$33.1K +131% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-22
2020 $25.3K +$19K +300% Oct 1, 2019 Sep 30, 2020 10-K/A 2022-05-31
2019 $6.33K Oct 1, 2018 Sep 30, 2019 10-K 2020-12-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.